<DOC>
	<DOCNO>NCT00001478</DOCNO>
	<brief_summary>Positron Emission Tomography ( PET ) technique use investigate functional activity brain . The PET technique allow doctor study normal biochemical metabolic process central nervous system normal individual patient neurologic illness without physical / structural damage brain . When region brain active , use fuel form oxygen sugar ( glucose ) . As brain use fuel produce waste product , carbon dioxide water . Blood carry fuel brain waste product away brain . As brain activity increase blood flow area activity increase also . Knowing fact , researcher use radioactive chemical ( H215O ) PET scan observe area brain receiving blood flow . Patients diagnose mood disorder healthy volunteer receive positron emission tomographic ( PET ) scan H215O simple task . Patients continue receive scan different mood state take different medication . Patients eligible study participate research study measure clinical biochemical parameter ( mood anxiety rating , medication response , psychological test result ) . Information gather H215O PET scan measure blood flow specific brain area compare data gather study . Objectives study ; 1 . To determine difference blood flow brain patient mood disorder compare healthy volunteer . 2 . To determine difference blood flow brain patient subtype mood disorder ( unipolar versus bipolar ) compare healthy volunteer . 2 . To determine change blood flow brain patient mood disorder experience spontaneous change symptoms 3 . To determine change blood flow brain patient mood disorder receive various kind therapy ( medication , transcranial magnetic stimulation , etc . ) 4 . To determine blood flow specific area brain use predict patient respond certain type therapy 5 . To compare blood flow change various clinical biochemical parameter .</brief_summary>
	<brief_title>Effects Drugs Cerebral Blood Flow Patients With Mood Disorders</brief_title>
	<detailed_description>Patients mood disorder healthy volunteer receive positron emission tomographic ( PET ) scan H ( 2 ) ( 15 ) O measure global local difference cerebral blood flow passive introspection task . Patients receive repeat scan different mood state participate placebo control therapeutic trial describe separate protocol . Global regional cerebral blood flow correlate data obtain participation protocol , include clinical ( life chart course illness parameter , mood anxiety rating , medication response data , psychological test performance ) biochemical ( level medication , monoamine peptide blood cerebrospinal fluid ) measure .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<criteria>Healthy volunteer patient satisfy DSMIIIR criterion mood disorder age 18 75 invited participate provide follow criterion fulfil : No history medical illness ( include seizure , endocrine , hepatic , renal , cardiac , allergic , infectious , autoimmune , neurological disorder ) would contraindicate participation . No evidence coexist major illness undergo complete psychiatric ( include SADSLA interview ) , medical , neurological , laboratory examination ( include EEG , EKG , renal liver function test , serum electrolyte , urinalysis , HIV , hepatitis B , syphilis ) . Negative pregnancy test woman child bear potential . Women must breast feeding . Negative HIV test , study primary mood anxiety disorder disorder secondary HIV infection . Negative urine comprehensive drug screen alcohol substance abuse problem last 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>Bupropion</keyword>
	<keyword>Carbamazepine</keyword>
	<keyword>Cerebral Blood Flow</keyword>
	<keyword>Gabapentin</keyword>
	<keyword>Lamotrigine</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Nimodipine</keyword>
	<keyword>Oxygen-15</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>